|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Arizona Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing ArizonaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Avant Diagnostics, Inc.
| | | Phone: | (480) 478-6660 | Year Established: | 2006 | Ticker: | AVDX | Exchange: | OTC | Main Contact: | Philippe Goix, PhD, MBA, President & CEO | | Other Contacts: | Jeffrey Busch, Chairman
| |
| Company Description | Avant, formerly Theranostics Health, is a medical diagnostic technology company that specializes in biomarker tests that are being developed and offered through its CLIA/CAP laboratory in the areas of oncology and neurology. Avant provides personalized medicine diagnostic testing capabilities through its TheraLink® Diagnostic Assays, primarily for breast cancer, to assist clinical oncologists in identifying likely responders for over 30 FDA-approved drug treatment regimens. Avant is the leading developer of proteomic technologies for measuring the activation status of key signaling pathways, with applications across several different cancer types, including breast, ovarian and pancreatic that are instrumental in the development of companion diagnostics for molecular-targeted therapies. Avant has used these proteomic technologies to support the drug development programs of many of the top biopharmaceutical companies in the world. | |
|
|
|
|
|